AzTrials
AzTrials

Periodontal DiseasesFLOE_longNCT07167771

LONGITUDINAL FOLLOW-UP STUDY TO DETERMINE THE PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED PATIENTS

An observational study of Periodontal Diseases, run by Universidad Complutense de Madrid at 2 sites in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Objective: The main aim of this longitudinal clinical study is to evaluate the predictive ability of a panel of salivary biomarkers in determining periodontal health status in 2 years follow up in a group of healthy and periodontally affected individuals. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Periodontal Diseases
How many people
100 participants
Where
2 sitesSpain
Study dates
1 Oct 2025to Oct 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: This study will be conducted as a 2y longitudinal, observational follow-up study, from a previous cross-sectional study (code 23/481-E). The study will be conducted at the Faculty of Dentistry University Complutense of Madrid, Spain. The research group and facilities associated with the university will serve as the primary study setting for participant recruitment, data collection, and analysis.

Who may be able to join

  • Participants from the cohort involved in the previous cross-sectional study (code 23/481-E).
  • Adults (≥ 18-year-old)
  • Being able to sign an informed consent form
  • Willing to participate in this observational investigation
  • Diagnosed as periodontally healthy, gingivitis, treated periodontitis patient (stable / unstable), periodontitis stages I \& II, or periodontitis stages III and IV (Papapanou et al. 2023) in the previous cross-sectional study (code 23/481-E)

Who cannot join

  • Patients fitting to all the above inclusion criteria will be excluded from the study if unable to attend to the study-related procedures.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Elena Figuero, Prof. contact

+34 913942186

elfiguer@ucm.es

Mariano Sanz, Prof. contact

+34 913942021

marsan@ucm.es

Spain2 sites, 2 recruiting
  • Faculty of Dentistry, University Complutense of Madrid (UCM)

    Madrid, 28040

    Elena Figuero Ruiz, 0034913942186, elfiguer@ucm.es

    Mariano Sanz, Prof.

    Recruiting
  • Faculty of Dentistry, University Complutense of Madrid (UCM)

    Madrid, 28040

    Elena Figuero, Prof., 0034913942186, elfiguer@ucm.es

    Claudia Sola, PhD student

    Recruiting

Other trials in Spain

About this study

Objective: The main aim of this longitudinal clinical study is to evaluate the predictive ability of a panel of salivary biomarkers in determining periodontal health status in 2 years follow up in a group of healthy and periodontally affected individuals.

Material and methods: In this longitudinal, observational follow-up study, patients previously enrolled in a cross-sectional study at the Periodontal Postgraduate Clinic, University Complutense of Madrid, will be re-evaluated over a 2-year period. Participants (≥18 years) will be categorized into diagnostic groups based on the 2018 classification of periodontal diseases, including periodontally healthy, gingivitis, treated periodontitis (stable/unstable), and various stages of periodontitis. The study will include follow-up visits at 1 and 2 years. At each visit, participants will undergo a comprehensive medical examination to assess age, gender, weight, height, waist circumference, blood pressure, temperature, smoking and alcohol history, systemic health, and HbA1c levels. A periodontal examination will be performed at six sites per tooth, and clinical parameters including plaque, bleeding on probing, probing depth, recession, and tooth loss will be recorded. Saliva and subgingival plaque samples will be collected for biomarker and microbiological analysis. Salivary biomarkers will be measured using multiplex immunoassays, and bacterial quantification will be performed by multiplex qPCR. Data analyses: Descriptive statistics will be used to report the clinical variables and patients will be grouped according to the pre-established diagnostic categories (periodontally healthy, gingivitis, treated periodontitis patient. In order to determine the possible statistical relationship with the medical, biochemical and microbiological variables assessed, a crude bivariate analysis will first be performed by applying a mean comparison test for quantitative variables (ANOVA) and a proportion comparison test for categorical variables (Chi-square). Subsequently, those variables identified as relevant in the crude analyses will be included as confounding and/or interaction factors in a binary logistic regression model, considering the presence of periodontitis as a response variable, in order to obtain crude and adjusted OR values, together with their corresponding 95% CIs. Based on the results obtained in the biomarker analysis, a relevant statistical analysis will be performed, taking into account all the variables collected in the study. For periodontitis cases, treatment response over time will be analyzed, with subgroup comparisons between responders and non-responders.

Being tested
No intervention
Keywords
periodontal diseases, saliva, biomarkers, prediction, periodontopathogens, interleukin 1, MMP-8
Medical subject headings
Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    There is not intervention in these patients, appart from their normal dental check-up visits.

Study groups in NCT07167771
Study groupRoleWhat they receive
Cohort 1Participants involved in an already done cross-sectional study (code 23/481-E).
Receives: Other: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Salivary biomarkers

    Concentrations of specific biomarkers (IL-1 and MMP-8) analyzed using multiplex commercial diagnostic tests.

    Measured: Baseline, 1 and 2 years

Secondary outcomes (18)
  1. Age

    Participant's age in years.

    Measured: Baseline, 1 and 2 years

  2. Gender

    Gender

    Measured: Baseline, 1 and 2 years

  3. Weight

    Weight (kg)

    Measured: Baseline, 1 and 2 years

  4. Height

    Height (cm)

    Measured: Baseline, 1 and 2 years

  5. Waist circumference

    A measuring tape will be used, and the determination will be made above the hip bone

    Measured: Baseline, 1 and 2 years

  6. HbA1c

    Following the instructions from the manufacturer of the device (A1CNow+; Bayer) and diabetic risk questionnaire (Finn-risk)

    Measured: Baseline, 1 and 2 years

  7. Blood pressure

    The procedure will follow the recommendations in the clinical practice guidelines of the American Heart Association (AHA) {Whelton, 2018 #466}. In summary, a validated and approved blood pressure monitor (Omron M6 COMFORT IT HEM-7322U-E) will be used with the patient seated, back straight, and arms supported at heart level. After the initial measurement, there will be a 5-minute rest period before taking a second reading. The average of the two readings will be considered valid.

    Measured: Baseline, 1 and 2 years

  8. Temperature

    Participant's body temperature in degrees Celsius.

    Measured: Baseline, 1 and 2 years

  9. Drug, alcohol, and smoking history

    History of participant's drug, alcohol, and smoking habits.

    Measured: Baseline, 1 and 2 years

  10. Nicotine dependency

    Assessment of nicotine dependency using the Fagerström Test for Nicotine Dependence.

    Measured: Baseline, 1 and 2 years

  11. Health anamnesis

    Relevant systemic health information collected through a complete health history questionnaire

    Measured: Baseline, 1 and 2 years

  12. Presence and quantification of specific periodontal pathogens

    1. gingivalis, A. actinomycetemcomitans, T. forsythia detected through real time PCR analysis

    Measured: Baseline, 1 and 2 years

  13. Plaque index

    categorized as presence/absence

    Measured: Baseline, 1 and 2 years

  14. Bleeding on probing

    assessed dichotomously within 15 seconds after probing

    Measured: Baseline, 1 and 2 years

  15. Suppuration on probing

    assessed dichotomously within 15 seconds after probing

    Measured: Baseline, 1 and 2 years

  16. Probing depth

    defined as the distance in mm between the bottom of the pocket and the gingival margin

    Measured: Baseline, 1 and 2 years

  17. Recession

    defined as the distance in mm between the amelocemental boundary and the gingival margin. The sum of probing depth and recession will determine the patient's clinical attachment loss

    Measured: Baseline, 1 and 2 years

  18. Number of teeth lost and reason

    Number of teeth lost and reason

    Measured: Baseline, 1 and 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2025
  2. Study start1 Oct 2025
  3. Primary completionOct 2027 (estimated)
  4. Study completionOct 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07167771
Sponsor's protocol ID
165-290725
Acronym
FLOE_long
Status last verified
Jun 2026
First submitted
4 Sep 2025
Last updated
29 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases, run by Universidad Complutense de Madrid at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elena Figuero, Prof. (+34 913942186, elfiguer@ucm.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Salivary biomarkers (time frame: Baseline, 1 and 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in